Rimner A, Lai WV, Califano R, Jabbour SK, et al. Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer. Clin Lung Cancer 2022 Apr 29. pii: S1525-7304(22)00058.
PMID: 35613997